Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Coronary heart disease (CHD)

Blood pressure reduction – how deep is deep enough?

    • Cardiology
    • Education
    • RX
  • 2 minute read

Coronary artery disease correlates closely with arterial hypertension. Therefore, to prevent damage to the left ventricular myocardium or the risk of stroke, blood pressure should be lowered. Only how far?

CHD and arterial hypertension are closely associated and may result in left ventricular myocardial damage. In addition, inadequately treated high blood pressure can also significantly increase the risk of stroke and kidney failure. The target is therefore a blood pressure below 140 mmHg/90 mmHg. However, many patients do not reach this value. In this context, one study found that patients with moderate cardiovascular risk in particular benefit significantly from blood pressure values below 130 mmHg systolic [2]. Reason enough for the American professional societies to adapt their guidelines accordingly. Since 2017, the American College of Cardiology guidelines have included an additional hypertension category, Stage 1 Hypertension. Accordingly, patients should already be treated at levels of 130-139 mmHg/80-89 mmHg [3].

However, not all experts share this attitude. Germany and Europe in particular are critical of the implementation of such low values. One reason is the particular patient profile of the study. High-risk patients with diabetes or a history of stroke were not studied. There is preliminary evidence that there may be a resurgence of cardiovascular events in certain patients when pressure falls below 120 mmHg.

The main point of criticism, however, lies in the blood pressure measurement itself. The measurements were carried out unattended, so that the “white coat effect” was absent. Therefore, incorrect, higher measured values may occur in everyday practice. Prof. Schunkert, Munich, also warns patients with CHD to be particularly cautious: “Too drastic a reduction with diastolic values below 60 mmHg can be problematic for patients with CHD because blood flow to the coronary vessels can be jeopardized, especially if constrictions are still present.” [4].

 

Literature:

  1. Busch M, Kuhnert R: Journal of Health Monitoring 2017; 2(1): 64-69.
  2. The SPRINT Research Group: N Engl J Med. 2015; 373: 2103-2116.
  3. Atasoy S, et al: European Heart Journal 2018.
  4. www.herzstiftung.de/sprint-studie-blutdruck-wie-tief-senken.html (last access: 01/26/2019)

 

CARDIOVASC 2019; 18(1): 32

Autoren
  • Leoni Burggraf
Publikation
  • CARDIOVASC
Related Topics
  • Blood pressure
  • CHD
  • coronary heart disease
  • Hypertension
Previous Article
  • Annual Meeting of the Swiss Brain Stroke Society, Zurich

PCSK9 inhibitors keep acute coronary syndrome at bay

  • Cardiology
  • Congress Reports
  • RX
  • Studies
View Post
Next Article
  • Left ventricular assist device (LVAD)

Heart failure: who benefits from mechanical circulatory support

  • Cardiology
  • Education
  • RX
  • Studies
  • Surgery
View Post
You May Also Like
View Post
  • 10 min
  • Irritable Bowel Syndrome

Functional disorder of gut-brain interaction – a biopsychosocial concept

    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • GLP1 receptor agonists

Positive influence on substance use and addiction

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • RX
    • Studies
View Post
  • 11 min
  • Sleep apnea and cardiovascular diseases

Breathless through the night

    • Cardiology
    • Education
    • General Internal Medicine
    • ORL
    • Pneumology
    • RX
    • Studies
View Post
  • 15 min
  • Diagnostics, differentiation and multimodal therapy

Vulvar diseases and vulvodynia

    • Dermatology and venereology
    • Education
    • Gynecology
    • Infectiology
    • RX
    • Studies
View Post
  • 3 min
  • From symptom to diagnosis

Abdominal pain – Prostate lipoma

    • Cases
    • Education
    • General Internal Medicine
    • Radiology
    • RX
    • Surgery
    • Urology
View Post
  • 6 min
  • Acute pulmonary embolism: new AHA/ACC guideline

Practical recommendations for risk-stratified triage

    • Cardiology
    • Education
    • Pneumology
    • RX
    • Studies
View Post
  • 13 min
  • Why lipoprotein(a) is the biggest therapeutic vacuum in cardiology

Lp(a): The underestimated risk factor before the turning point

    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • RX
    • Studies
View Post
  • 11 min
  • Modern system therapeutics for hidradenitis suppurativa

Immunological dysregulation in the sights of several biologics and “small molecules”

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • RX
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Functional limb preservation between infection control, vascular medicine and resurfacing
  • 2
    Do special amino acids lead to success?
  • 3
    Do special amino acids lead to success?
  • 4
    Current status of PAT
  • 5
    Surgical wound complications

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.